AMSBIO has assembled an extensive collection of autophagy antibodies. From the industry standard autophagy antibody APG8 (MAPLC3) to the newest autophagy antibodies such as LAMP and APG1, AMSBIO is able to provide the most relevant, qualified antibodies for autophagy research.
Autophagy is a cellular process not only implicated in the death of a cell, but more widely implicated in the survival of a cell. Autophagy functions as a housekeeping mechanism through disposal of aging and/or dysfunctional proteins and organelles by isolating and preparing these proteins for lysosomal degradation. Targeting autophagy as a therapeutic method is of growing interest to many researchers specializing in a diverse range of diseases from bacterial and viral infections to cancer and more recently in neurodegeneration and other ageing-related diseases.
Mitochondrial dysfunction has also become increasingly linked to various diseases, with mitophagy playing an important role in mitochondrial dynamics. AMSBIO provide a MitoXpress® Xtra Oxygen Consumption Assay for analysis in real-time of mitochondrial function using fluorescence plate readers.
AMSBIO offers a comprehensive range of products related to autophagy for almost every gene and target of interest. To find the antibody, cDNA clone, RNAi, lentiviral or adenoviral services related to your target of interest please visit http://www.amsbio.com/autophagy.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com . In April 2016, AMSBIO will be sponsoring the Autophagy UK network conference in Edinburgh - see http://autophagy.uk/ for further information.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective. Custom services include stable cell line production, CRISPR/Cas9 Genome Editing, lentivirus and adenovirus production, large scale protein production and a comprehensive portfolio of antibody services.
---------------------
Worldwide HQ
AMS Biotechnology (AMSBIO)
184 Milton Park
Abingdon
Oxon OX14 4SE
UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com
Web www.amsbio.com
North American HQ
AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com
Web www.amsbio.com